Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 20 | 2026 | 227 | 9.100 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2026 | 2262 | 3.080 |
Why?
|
| Brain | 9 | 2026 | 1625 | 1.640 |
Why?
|
| Biomarkers | 5 | 2024 | 1487 | 1.300 |
Why?
|
| Inflammation | 5 | 2025 | 1195 | 0.990 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2026 | 34 | 0.870 |
Why?
|
| Gadolinium | 1 | 2025 | 110 | 0.820 |
Why?
|
| Mindfulness | 1 | 2024 | 72 | 0.780 |
Why?
|
| Roseolovirus Infections | 2 | 2019 | 11 | 0.720 |
Why?
|
| Spinal Cord | 4 | 2026 | 210 | 0.710 |
Why?
|
| Herpesvirus 6, Human | 2 | 2019 | 18 | 0.710 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 327 | 0.700 |
Why?
|
| Diabetic Nephropathies | 1 | 2021 | 38 | 0.660 |
Why?
|
| Cervical Cord | 1 | 2020 | 5 | 0.660 |
Why?
|
| Loneliness | 1 | 2020 | 18 | 0.640 |
Why?
|
| Monocytes | 2 | 2021 | 361 | 0.640 |
Why?
|
| Spondylosis | 1 | 2020 | 26 | 0.630 |
Why?
|
| Neuroimaging | 4 | 2026 | 165 | 0.630 |
Why?
|
| Stress, Psychological | 1 | 2024 | 475 | 0.610 |
Why?
|
| Limbic Encephalitis | 1 | 2018 | 1 | 0.570 |
Why?
|
| Encephalitis, Viral | 1 | 2018 | 5 | 0.570 |
Why?
|
| Humans | 30 | 2026 | 65645 | 0.540 |
Why?
|
| Lymphocytes | 1 | 2019 | 209 | 0.530 |
Why?
|
| Seizures | 1 | 2018 | 141 | 0.530 |
Why?
|
| Melanoma | 1 | 2021 | 334 | 0.510 |
Why?
|
| Retrospective Studies | 8 | 2026 | 6948 | 0.470 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 410 | 0.470 |
Why?
|
| Neutrophils | 1 | 2019 | 396 | 0.460 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 355 | 0.450 |
Why?
|
| Male | 17 | 2026 | 31292 | 0.440 |
Why?
|
| Adult | 13 | 2026 | 17511 | 0.440 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2026 | 188 | 0.430 |
Why?
|
| Middle Aged | 11 | 2026 | 18439 | 0.420 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 733 | 0.410 |
Why?
|
| Female | 16 | 2026 | 34309 | 0.380 |
Why?
|
| MicroRNAs | 1 | 2019 | 714 | 0.360 |
Why?
|
| Attention | 2 | 2010 | 154 | 0.340 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1335 | 0.340 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 2730 | 0.330 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2026 | 300 | 0.320 |
Why?
|
| Motor Skills Disorders | 1 | 2010 | 5 | 0.310 |
Why?
|
| Serial Learning | 1 | 2010 | 6 | 0.310 |
Why?
|
| Cohort Studies | 3 | 2020 | 2639 | 0.300 |
Why?
|
| Psychomotor Performance | 1 | 2010 | 137 | 0.290 |
Why?
|
| Atrophy | 2 | 2019 | 87 | 0.280 |
Why?
|
| Longitudinal Studies | 2 | 2025 | 1288 | 0.280 |
Why?
|
| Visual Cortex | 1 | 2007 | 27 | 0.260 |
Why?
|
| Face | 1 | 2007 | 36 | 0.260 |
Why?
|
| Action Potentials | 1 | 2007 | 113 | 0.250 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2026 | 704 | 0.230 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 270 | 0.230 |
Why?
|
| White Matter | 1 | 2026 | 128 | 0.220 |
Why?
|
| Quality of Life | 2 | 2024 | 1265 | 0.210 |
Why?
|
| Prospective Studies | 2 | 2024 | 3329 | 0.210 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2023 | 19 | 0.200 |
Why?
|
| Cerebral Veins | 1 | 2024 | 38 | 0.200 |
Why?
|
| Consensus | 1 | 2024 | 177 | 0.200 |
Why?
|
| Antigens, Viral | 1 | 2023 | 130 | 0.190 |
Why?
|
| Hydrocortisone | 1 | 2024 | 192 | 0.190 |
Why?
|
| Capsid Proteins | 1 | 2023 | 107 | 0.190 |
Why?
|
| Machine Learning | 1 | 2025 | 196 | 0.190 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2023 | 105 | 0.180 |
Why?
|
| Proteomics | 1 | 2024 | 299 | 0.180 |
Why?
|
| Contrast Media | 1 | 2025 | 432 | 0.180 |
Why?
|
| Herpesvirus 4, Human | 1 | 2023 | 199 | 0.180 |
Why?
|
| Albumins | 1 | 2022 | 43 | 0.180 |
Why?
|
| Serum Albumin | 1 | 2021 | 47 | 0.170 |
Why?
|
| Albuminuria | 1 | 2021 | 28 | 0.170 |
Why?
|
| Creatinine | 1 | 2021 | 136 | 0.170 |
Why?
|
| Alemtuzumab | 1 | 2020 | 11 | 0.170 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 110 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 58 | 0.160 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 121 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2024 | 1026 | 0.160 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2021 | 55 | 0.160 |
Why?
|
| Placebos | 1 | 2020 | 73 | 0.160 |
Why?
|
| Immunologic Factors | 1 | 2020 | 108 | 0.150 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2019 | 13 | 0.150 |
Why?
|
| Encephalitis | 1 | 2019 | 39 | 0.150 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 104 | 0.140 |
Why?
|
| Epilepsy | 1 | 2019 | 113 | 0.140 |
Why?
|
| Photic Stimulation | 2 | 2010 | 89 | 0.140 |
Why?
|
| Alcoholism | 1 | 2021 | 329 | 0.140 |
Why?
|
| Chronic Pain | 1 | 2020 | 157 | 0.130 |
Why?
|
| Electroencephalography | 1 | 2018 | 156 | 0.130 |
Why?
|
| Viral Load | 1 | 2018 | 230 | 0.130 |
Why?
|
| Acute Disease | 1 | 2018 | 663 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 429 | 0.120 |
Why?
|
| Logistic Models | 1 | 2019 | 1273 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 691 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 710 | 0.110 |
Why?
|
| Risk Factors | 1 | 2020 | 5466 | 0.080 |
Why?
|
| Color Perception | 1 | 2010 | 4 | 0.080 |
Why?
|
| Reaction Time | 1 | 2010 | 134 | 0.070 |
Why?
|
| Cues | 1 | 2010 | 81 | 0.070 |
Why?
|
| Child | 1 | 2018 | 4634 | 0.070 |
Why?
|
| Aged | 2 | 2026 | 15089 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2010 | 606 | 0.070 |
Why?
|
| Stereognosis | 1 | 2007 | 2 | 0.070 |
Why?
|
| Occipital Lobe | 1 | 2007 | 17 | 0.060 |
Why?
|
| Touch | 1 | 2007 | 27 | 0.060 |
Why?
|
| Pattern Recognition, Visual | 1 | 2007 | 38 | 0.060 |
Why?
|
| Auditory Perception | 1 | 2007 | 43 | 0.060 |
Why?
|
| Observer Variation | 1 | 2026 | 216 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 231 | 0.050 |
Why?
|
| Infliximab | 1 | 2022 | 50 | 0.050 |
Why?
|
| Time Factors | 1 | 2010 | 3777 | 0.050 |
Why?
|
| Adolescent | 2 | 2010 | 6350 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2026 | 1715 | 0.040 |
Why?
|
| Social Class | 1 | 2021 | 137 | 0.040 |
Why?
|
| Placebo Effect | 1 | 2020 | 10 | 0.040 |
Why?
|
| Deception | 1 | 2020 | 7 | 0.040 |
Why?
|
| Phenotype | 1 | 2024 | 1235 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 964 | 0.040 |
Why?
|
| Ethics, Medical | 1 | 2020 | 40 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2020 | 127 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 604 | 0.040 |
Why?
|
| Young Adult | 1 | 2010 | 4855 | 0.040 |
Why?
|
| Mental Health | 1 | 2021 | 364 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2020 | 745 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 505 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2007 | 62 | 0.020 |
Why?
|
| Blindness | 1 | 2007 | 43 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2007 | 240 | 0.010 |
Why?
|
| Oxygen | 1 | 2007 | 321 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 21459 | 0.010 |
Why?
|